248 related articles for article (PubMed ID: 10514468)
21. Thyroid hormone (T3) inhibits ciprofibrate-induced transcription of genes encoding beta-oxidation enzymes: cross talk between peroxisome proliferator and T3 signaling pathways.
Chu R; Madison LD; Lin Y; Kopp P; Rao MS; Jameson JL; Reddy JK
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11593-7. PubMed ID: 8524810
[TBL] [Abstract][Full Text] [Related]
22. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
[TBL] [Abstract][Full Text] [Related]
23. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms.
Ram PA; Waxman DJ
J Biol Chem; 1999 Dec; 274(50):35553-61. PubMed ID: 10585430
[TBL] [Abstract][Full Text] [Related]
24. A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding.
Hsu MH; Palmer CN; Song W; Griffin KJ; Johnson EF
J Biol Chem; 1998 Oct; 273(43):27988-97. PubMed ID: 9774413
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain.
Juge-Aubry CE; Hammar E; Siegrist-Kaiser C; Pernin A; Takeshita A; Chin WW; Burger AG; Meier CA
J Biol Chem; 1999 Apr; 274(15):10505-10. PubMed ID: 10187842
[TBL] [Abstract][Full Text] [Related]
26. Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.
Krogsdam AM; Nielsen CA; Neve S; Holst D; Helledie T; Thomsen B; Bendixen C; Mandrup S; Kristiansen K
Biochem J; 2002 Apr; 363(Pt 1):157-65. PubMed ID: 11903058
[TBL] [Abstract][Full Text] [Related]
27. Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.
Inoue I; Itoh F; Aoyagi S; Tazawa S; Kusama H; Akahane M; Mastunaga T; Hayashi K; Awata T; Komoda T; Katayama S
Biochem Biophys Res Commun; 2002 Jan; 290(1):131-9. PubMed ID: 11779144
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of peroxisome proliferator signaling pathways by thyroid hormone receptor. Competitive binding to the response element.
Miyamoto T; Kaneko A; Kakizawa T; Yajima H; Kamijo K; Sekine R; Hiramatsu K; Nishii Y; Hashimoto T; Hashizume K
J Biol Chem; 1997 Mar; 272(12):7752-8. PubMed ID: 9065436
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
Luo G; Yu-Lee L
J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
[TBL] [Abstract][Full Text] [Related]
30. Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1.
Ito M; Yu RN; Jameson JL
Mol Endocrinol; 1998 Feb; 12(2):290-301. PubMed ID: 9482669
[TBL] [Abstract][Full Text] [Related]
31. A pan-PPAR ligand induces hepatic fatty acid oxidation in PPARalpha-/- mice possibly through PGC-1 mediated PPARdelta coactivation.
Røst TH; Haugan Moi LL; Berge K; Staels B; Mellgren G; Berge RK
Biochim Biophys Acta; 2009 Nov; 1791(11):1076-83. PubMed ID: 19577662
[TBL] [Abstract][Full Text] [Related]
32. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.
Krey G; Braissant O; L'Horset F; Kalkhoven E; Perroud M; Parker MG; Wahli W
Mol Endocrinol; 1997 Jun; 11(6):779-91. PubMed ID: 9171241
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor.
Chung SW; Kang BY; Kim TS
Mol Pharmacol; 2003 Nov; 64(5):1169-79. PubMed ID: 14573767
[TBL] [Abstract][Full Text] [Related]
34. Role of hepatocyte nuclear factors in transcriptional regulation of male-specific CYP2A2.
Wiwi CA; Waxman DJ
J Biol Chem; 2005 Feb; 280(5):3259-68. PubMed ID: 15539409
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
36. A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo.
Lee SK; Anzick SL; Choi JE; Bubendorf L; Guan XY; Jung YK; Kallioniemi OP; Kononen J; Trent JM; Azorsa D; Jhun BH; Cheong JH; Lee YC; Meltzer PS; Lee JW
J Biol Chem; 1999 Nov; 274(48):34283-93. PubMed ID: 10567404
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
38. Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor alpha and liver-X-receptor alpha.
Miyata KS; McCaw SE; Meertens LM; Patel HV; Rachubinski RA; Capone JP
Mol Cell Endocrinol; 1998 Nov; 146(1-2):69-76. PubMed ID: 10022764
[TBL] [Abstract][Full Text] [Related]
39. A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity.
Gervois P; Torra IP; Chinetti G; Grötzinger T; Dubois G; Fruchart JC; Fruchart-Najib J; Leitersdorf E; Staels B
Mol Endocrinol; 1999 Sep; 13(9):1535-49. PubMed ID: 10478844
[TBL] [Abstract][Full Text] [Related]
40. The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1.
Børud B; Hoang T; Bakke M; Jacob AL; Lund J; Mellgren G
Mol Endocrinol; 2002 Apr; 16(4):757-73. PubMed ID: 11923473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
